Pfizer settles largest ever fraud suit for off-label promotion

被引：0

|

作者：

Mark Ratner

机构：

来源：

Nature Biotechnology | 2009年 / 27卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：961 / 962

页数：1

相关论文

共 50 条

[1] Pfizer settles largest ever fraud suit for off-label promotion
Ratner, Mark
[J]. NATURE BIOTECHNOLOGY, 2009, 27 (11) : 961 - 962
[2] Off-Label Promotion of Prescription Medicine: Is It Ever Justifiable?
Ghinea, Narcyz
Lipworth, Wendy
Kerridge, Ian
[J]. THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (03) : 359 - 363
[3] Pfizer pays record fine for off-label promotion of four drugs
Tanne, Janice Hopkins
[J]. BRITISH MEDICAL JOURNAL, 2009, 339
[4] Off-label promotion
Kuehn, BM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (06): : 673 - 673
[5] Off-label drug promotion
不详
[J]. ONCOLOGY-NEW YORK, 1999, 13 (12): : 1616 - 1616
[6] Government investigations in the pharmaceutical industry: Off-label promotion, fraud and abuse, and false claims
Kalb, PE
Bass, IS
[J]. FOOD AND DRUG LAW JOURNAL, 1998, 53 (01): : 63 - 70
[7] Off-Label Drug Use and Promotion
Gianutsos, Gerald
[J]. US PHARMACIST, 2014, 39 (10) : 55 - 64
[8] Origins of the Prohibition Against Off-Label Promotion
Coleman, Terry S.
[J]. FOOD AND DRUG LAW JOURNAL, 2014, 69 (02) : 161 - 236
[9] What Is "False or Misleading" Off-Label Promotion?
Bi, Kathryn
[J]. UNIVERSITY OF CHICAGO LAW REVIEW, 2015, 82 (02): : 975 - 1021
[10] Off-Label Drug Promotion and the Use of Disclaimers
McKenney, Dina
[J]. TEXAS LAW REVIEW, 2013, 92 (01) : 231 - 252

← 1 2 3 4 5 →